The sales revenue of the BioTechUSA company group increased by 40 percent last year
The BioTechUSA company group closed the year 2022 with a record financial result, its sales revenue increased by 41 percent and reached HUF 80.4 billion, its earnings before interest, taxes and depreciation (EBITDA) increased from HUF 9.2 billion to HUF 11.5 billion.
The Hungarian family-owned group of companies expanded its portfolio with 300 new products, opened 17 new stores and launched the largest investment in its history in 2022, which will continue this year – explained Bálint Lévai, CEO and co-owner of BioTechUSA Kft., at the press conference presenting the company’s annual results.
About 80 percent of the total sales revenue of one of the largest food supplement and specialty food manufacturing and distribution groups in Europe last year came from exports, and the international store network produced a 216 percent increase in turnover.
Related news
With two mugs to survive – this is how Hungarian small breweries closed 2024
The players in the domestic small-scale beer market mostly reported…
Read more >Improving results despite declining sales: Alföldi Tej Kft. stabilizes after a difficult year
Alföldi Tej Kft. took a breather in 2024: although the…
Read more >BioTechUSA’s new premium vitamin product line is here
This spring, BioTechUSA launched a new, premium vitamin product line,…
Read more >Related news
A large wave of price increases is expected in trade
In the first half of 2025, GKI Economic Research Ltd.…
Read more >Children’s future is at stake now – you can vote in 198 Tesco stores
In 198 Tesco stores across the country, customers can vote…
Read more >Inflation accelerated to 2 percent in the eurozone and 2.3 percent in the EU on an annual basi
Inflation in the euro area and the European Union accelerated…
Read more >